Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-01

FDA Approved: MENOSTAR — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MENOSTAR (estradiol) submitted by Bayer HealthCare Pharmaceuticals Inc. to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MENOSTAR (ESTRADIOL)

Snippet

SUPPL AP for MENOSTAR (ESTRADIOL)